Patent · US Expired

O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants

US6440990B1 · kind B1 · utility

49Cited by

9References

35Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Sylvain Cottens · Witterswil, CH
Richard Sedrani · Basel, CH

Key dates

Filing date	May 23, 1997
Grant date	Aug 27, 2002
Priority date	—
Expiry date	May 23, 2017

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel derivatives of rapamycin, particularly 9-deoxo-rapamycins, 26-dihydro-rapamycins, and 40-O-substituted and 28,40-O,O-disubstituted rapamycins. are found to have pharmaceutical utility, particularly as immunosuppressants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.